Blockage of Intermediate-Conductance Ca2+-Activated K + Channels Inhibit Human Pancreatic Cancer Cell Growth in Vitro

Molecular Pharmacology

Volumn 65, Issue 3, 2004, Pages 630-638

  Jäger, Heike ^a   Dreker, Tobias ^a   Buck, Anita ^a   Giehl, Klaudia ^a   Gress, Thomas ^a   Grissmer, Stephan ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 [(2 CHLOROPHENYL)DIPHENYLMETHYL] 1H PYRAZOLE; BARIUM ION; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CHARYBDOTOXIN; CLOTRIMAZOLE; DILTIAZEM; ION CHANNEL; MESSENGER RNA; NIFEDIPINE; PYRAZOLE DERIVATIVE; TRAM 34; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS TUMOR; PATCH CLAMP; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL COUNT; CELL DIVISION; GENE EXPRESSION; HUMANS; PANCREATIC NEOPLASMS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 10744229065     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.65.3.630     Document Type: Article

References (47)

1. + channels by cytochrome P-450 inhibitors. J Biol Chem 267:11789-11793.
2. Ayub M and Levell MJ (1990) The inhibition of human prostatic aromatase activity by imidazole drugs including ketoconazole and 4-hydroxyandrostenedione. Biochem Pharmacol 40:1569-1575.
3. Berrozpe G, Schaeffer J, Peinado MA, Real FX, and Perucho M (1994) Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int J Cancer 58:185-191.
4. Brugnara C, Gee B, Armsby CC, Kurth S, Sakamoto M, Rifai N, Alper SL, and Platt OS (1996) Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J Clin Investig 97:1227-1234.
5. Catterall WA, Chandy KG, and Gutman GA (2002). The IUPHAR compendium of voltage gated potassium channels. IUPHAR Media, Leeds, UK.
6. + channels in human T lymphocytes: a role in mitogenesis? Nature (Lond) 307:465-468.
7. + channel. Am J Physiol 271:L775-L784.
8. Fanger CM, Ghanshani S, Logsdon NJ, Rauer H, Kalman K, Zhou J, Beckingham K, Chandy KG, Cahalan MD, and Aiyar J (1999) Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1. J Biol Chem 274:5746-5754.
9. Fujimoto K, Hosotani R, Miyamoto Y, Doi R, Koshiba T, Otaka A, Fujii N, Beauchamp RD, and Imamura M (2000) Inhibition of pRb phosphorylation and cell cycle progression by an antennapedia-p16(INK4A) fusion peptide in pancreatic cancer cells. Cancer Lett 159:151-158.
10. Gardos G (1958) The function of calcium in the potassium permeability of human erythrocytes. Biochim Biophys Acta 30:653-654.
11. Ghanshani S, Wulff H, Miller MJ, Rohm H, Neben A, Gutman GA, Cahalan MD, and Chandy KG (2000) Up-regulation of the IKCa1 potassium channel during T-cell activation. J Biol Chem 275:37137-37149.
12. Giehl K, Skripczynski B, Mansard A, Menke A, and Gierschik P (2000) Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration. Oncogene 19:2930-2942.
13. Gress TM, Müller-Pillasch F, Geng M, Zimmerhackl F, Zehetner G, Friess H, Büchler M, Adler G, and Lehrach H (1996) A pancreatic cancer-specific expression profile. Oncogene 13:1819-1830.
14. Grissmer S, Nguyen AN, and Cahalan MD (1993) Calcium-activated potassium channels in resting and activated human T lymphocytes. Expression levels, calcium dependence, ion selectivity and pharmacology. J Gen Physiol 102:601-630.
15. Hamill OP, Marty A, Neher E, Sakmann B, and Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pfluegers Arch Eur J Physiol 391:85-100.
16. Hruban RH, Iacobuzio-Donahue C, Wilentz RE, Goggins M, and Kern SE (2001) Molecular pathology of pancreatic cancer. Cancer J 7:251-258.
17. Ishii TM, Silvia C, Hirschberg B, Bond CT, Adelman JP, and Maylie J (1997) A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci USA 94:11651-11656.
18. 2+-activated potassium channels in human leukemic T cells and activated human peripheral blood T lymphocytes. Cell Physiol Biochem 7:179-187.
19. + channels in the human leukemic T cell line, Jurkat. FEBS Lett 469:196-202.
20. + channels. Proc Natl Acad Sci USA 96:10917-10921.
21. + channel of intermediate conductance: a molecular target for novel treatments? Current Drug Targets 2:401-422.
22. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA, and Jacks T (2001) Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature (Lond) 410:1111-1116.
23. Joiner WJ, Wang LY, Tang MD, and Kaczmarek LK (1997) hSK4, a member of a novel subfamily of calcium-activated potassium channels. Proc Natl Acad Sci USA 94:11013-11018.
24. Logsdon NJ, Kang J, Togo JA, Christian EP, and Aiyar J (1997) A novel gene, hKCa4, encodes the calcium-activated potassium channel in human T lymphocytes. J Biol Chem 272:32723-32726.
25. Khanna R, Chang MC, Joiner WJ, Kaczmarek LK, and Schlichter LC (1999) hSK4/hIK1, a calmodulin-binding KCa channel in human T lymphocytes. Roles in proliferation and volume regulation. J Biol Chem 274:14838-14849.
26. Lewis RS and Cahalan MD (1995) Potassium and calcium channels in lymphocytes. Annu Rev Immunol 13:623-653.
27. Matteson DR and Deutsch C (1984) K channels in T lymphocytes: a patch clamp study using monoclonal antibody adhesion. Nature (Lond) 307:468-471.
28. Maurice M, Pichard L, Daujat M, Fabre I, Joyeux H, Domergue J, and Maurel P (1992) Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB J 6:752-758.
29. Moore PS, Sipos B, Orlandini S, Sorio C, Real FX, Lemoine NR, Gress T, Bassi C, Kloppel G, Kalthoff H, Ungefroren H, et al. (2001) Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch 439:798-802.
30. Nguyen TD and Moody MW (1998) Calcium-activated potassium conductances on cultured nontransformed dog pancreatic duct epithelial cells. Pancreas 17:348-358.
31. Nilius B and Wohlrab W (1992) Potassium channels and regulation of proliferation of human melanoma cells. J Physiol 45:537-548.
32. Pappas CA and Ritchie JM (1998) Effect of specific ion channel blockers on cultured Schwann cell proliferation. Glia 22:113-120.
33. + channels. EMBO (Eur Mol Biol Organ) J 18:5540-5547.
34. ca channel FIK is a common mechanism for basic fibroblast growth factor and transforming growth factor-β suppression of myogenesis. J Biol Chem 275:13677-13682.
35. Portzehl H, Caldwell PC, and Ruegg JC (1964) The dependence of concentration and relaxation of muscle fibres from the crab Maia squinado on the intracellular concentration of free calcium ions. Biochim Biophys Acta 79:581-591.
36. Rane SG (1999) Ion channels as physiological effectors for growth factor receptor and Ras/ERK signaling pathways. Adv Second Messenger Phosphoprotein Res 33:107-127.
37. Rodrigues AD, Gibson GG, Ioannides C, and Parke DV (1987) Interactions of imidazole antifungal agents with purified cytochrome P-450 proteins. Biochem Pharmacol 36:4277-4281.
38. + channel block-induced mammalian neuroblastoma cell swelling: a possible mechanism to influence proliferation. J Physiol 510:93-102.
39. + channels in the proliferation of pancreatic carcinoma cells. Biophys J 80:101a.
40. + conductances. Demonstration of efficacy in intact rabbit colon and in an in vivo mouse model of cholera. J Clin Investig 100:3111-3120.
41. Singh S, Syme CA, Singh AK, Devor DC, and Bridges RJ (2001) Benzimidazolone activators of chloride secretion: potential therapeutics for cystic fibrosis and chronic obstructive pulmonary disease. J Pharmacol Exp Ther 296:600-611.
42. Seufferlein T, Van Lint J, Liptay S, Adler G, and Schmid RM (1999) Transforming growth factor alpha activates Ha-Ras in human pancreatic cancer cells with Ki-ras mutations. Gastroenterology 116:1441-1452.
43. Strobl JS, Wonderlin WF, and Flynn D (1995) Mitogenic signal transduction in human breast cancer cells. Gen Pharmacol 26:1643-1649.
44. + channel, mIK1. Roles in regulatory volume decrease and erythroid differentiation. J Biol Chem 273:21542-21553.
45. Wallrapp C, Müller-Pillasch F, Solinas-Toldo S, Lichter P, Friess H, Büchler M, Adler G, and Gress TM (1997) Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies myb as candidate oncogene. Cancer Res 57:3135-3139.
46. + channel IKCa1: A potential immunosuppressant. Proc Natl Acad Sci USA 97:8151-8156.
47. Yip-Schneider MT, Lin A, and Marshall MS (2001) Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2. Biochem Biophys Res Commun 280:992-997.